Use of alpha 2 adrenergic receptor agonists for treating or preventing psoriasis

Details for Australian Patent Application No. 2010332233 (hide)

Owner Galderma Laboratories LP

Inventors Dejovin, Jack A.

Agent Davies Collison Cave

Pub. Number AU-A-2010332233

PCT Pub. Number WO2011/075267

Priority 12/621,942 19.11.09 US

Filing date 18 November 2010

Wipo publication date 23 June 2011

International Classifications

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/417 (2006.01)

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61P 17/06 (2006.01) Drugs for dermatological disorders

Event Publications

14 June 2012 PCT application entered the National Phase

  PCT publication WO2011/075267 Priority application(s): WO2011/075267

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010332234-Enhanced convection for in situ pyrolysis of organic-rich rock formations

2010332230-Docking station with temperature control and electronic identification system